Matthew B. Schlenker is an Assistant Professor and University of Toronto Glaucoma, Cataract, & Anterior Segment surgeon at Kensington Eye Institute, Trillium Health Partners, and Toronto Western Hospital. He received his Bachelor’s Degree (Magna Cum Laude) in Economics from Yale University and then worked as a financial analyst at Bear Stearns and as a business analyst at McKinsey & Co. He received his MD (with Honours) and Ophthalmology training at the University of Toronto, where he was a Chief Resident. He then completed a Glaucoma and Advanced Anterior Segment Fellowship at Trillium Health Partners and a Master of Science in Epidemiology at the Harvard School of Public Health.

He is the Chair of Resident Research in the Department of Ophthalmology & Vision Sciences at U. of T. and sits on the Kensington Research Committee. He is a regular presenter at both local and international academic conferences and has published in Ophthalmology, American Journal of Ophthalmology, British Journal of Ophthalmology, Journal of Cataract and Refractive Surgery, among other journals.

Financial disclosure: Dr. Schlenker has/had an affiliation (financial or otherwise) with a commercial organization:

1. Aeques
2. Alcon
3. Allergan
4. Bausch & Lomb
5. Johnson & Johnson
6. Santen
7. Thea-Labtician